A major contribution to immunotherapy was the discovery of the immune evasion mechanism, mediated through the expression of B7-H1 on the surface of melanoma cells, which was later described as programmed cell death ligand-1 (PD-L1) [50]. The gene discussed is CD274; the disease is melanoma.